Cassava Sciences, Inc.
SAVA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$10,807 | -$44,224 | -$23,403 | -$27,597 |
| Dep. & Amort. | $131 | $218 | $220 | $260 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4,402 | $4,581 | $5,225 | $0 |
| Change in WC | $53 | $34,478 | $6,622 | -$39,672 |
| Other Non-Cash | $0 | $0 | $0 | $5,744 |
| Operating Cash Flow | -$6,221 | -$4,947 | -$11,336 | -$61,265 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$80 | $0 | $0 | -$57 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$80 | $0 | $0 | -$57 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $90 | $918 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $90 | $918 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$6,301 | -$4,947 | -$11,246 | -$60,404 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $112,381 | $117,328 | $128,574 | $188,978 |
| End Cash | $106,080 | $112,381 | $117,328 | $128,574 |
| Free Cash Flow | -$6,301 | -$4,947 | -$11,336 | -$61,322 |